Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?

Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?

We have studied the effects of add-on spironolactone treatment (100 mg/day) in 11 patients with idiopathic membranous nephropathy (IMN) and > 3 gm proteinuria/day despite angiotensin converting enzyme (ACE) inhibitor therapy titrated to a systolic/diastolic blood pressure < 120/80 mmHg...

Full description

Bibliographic Details
Main Authors: Giuseppe Remuzzi, Ruth Campbell, Piero Ruggenenti, Varusca Brusegan, Paolo Cravedi
Format: Article
Language:English
Published: MDPI AG 2010-01-01
Series:Pharmaceuticals
Subjects:
idiopathic membranous nephropathy
spironolactone
proteinuria
hyperkalemia
Online Access:http://www.mdpi.com/1424-8247/3/1/1/

Internet

http://www.mdpi.com/1424-8247/3/1/1/

Similar Items